Manufacturer and distributor of over-the-counter and prescription medicines with production in Germany
Strathmann GmbH & Co. KG
Hamburg · Seevetal · BudapestNew on Amplifa
Pharmaceutical expertise from the Hanseatic city
Strathmann GmbH & Co. KG is a mid-sized pharmaceutical company headquartered in Hamburg and has been part of the Dermapharm corporate group since 2018. The company is active as a pharmaceutical entrepreneur and manufacturing operation in the fields of self-medication (OTC) and prescription medicines. Its product range includes brands such as Thym-Uvocal, Ebenol, Antiscabiosum, Pollstimol, StroVac, Gynatren, Myopridin and Mydocalm. The medicines are produced in Germany with short supply routes; the active ingredients come predominantly from Europe. At the Seevetal site, manufacturing, quality control, release according to LFGB, GMP and AMG, and the packaging of solid dosage forms take place; the company also maintains a warehouse with 1680 pallet spaces. The Hamburg headquarters is responsible for purchasing, medical-scientific support, pharmacovigilance, quality assurance and Regulatory Affairs and is GDP-certified. With around 65 employees at the Hamburg, Seevetal and Budapest sites, Strathmann additionally offers contract manufacturing.
- Site
- Hamburg
- Processes
- Manufacture of medicines (manufacturing operation), Packaging of solid dosage forms, Quality control and releases (LFGB, GMP, AMG), Manufacture of medicines (production in Germany), Warehouse/logistics, Contract manufacturing (offered as a topic in the contact form), Pharmacovigilance, Regulatory Affairs
- Materials
- Protein hydrolysate (thymus peptides), Benzyl benzoate, Hydrocortisone, Calcium, Colecalciferol (vitamin D3), Zinc, Selenium, Pridinol
- Certificates
- GDP, GMP, Releases according to LFGB, GMP, AMG
- Founded
- 1974
- Employees
- 65
- Industries
- Pharmaceutical industry, Healthcare, Self-medication (OTC), Prescription medicines
- 01
Procurement of active ingredients (predominantly from Europe)
- 02
Manufacturing in Seevetal
- 03
Quality control
- 04
Releases according to LFGB, GMP and AMG
- 05
Packaging of solid dosage forms
- 06
Warehousing and logistics
- 07
Distribution (pharmacies, wholesalers, hospitals)
- 08
Pharmacovigilance
Active ingredients and preparations
Protein hydrolysate (thymus peptides)
Active ingredient in Thym-Uvocal plus, obtained from the thymus of cattle from New Zealand or the EU.
Benzyl benzoate
Active ingredient of the Antiscabiosum emulsion for the treatment of scabies.
Hydrocortisone
Active ingredient of the Ebenol creams for relief of inflammatory skin conditions.
Calcium and colecalciferol (vitamin D3)
Active ingredients of the chewable tablet Adcal-D3, whose manufacture Strathmann took over exclusively in 1999.
Tolperisone hydrochloride / pridinol
Active ingredients of the muscle relaxants Mydocalm and Myopridin.
Lactobacillus strains
Basis of the vaccines StroVac and Gynatren for immunotherapy.
Sites
Hamburg
DEHeadquarters: purchasing, medical-scientific support, pharmacovigilance, quality assurance, Regulatory Affairs
Seevetal
DEProduction, quality control, releases according to LFGB, GMP and AMG, packaging of solid dosage forms, warehouse
- Materials
- Tablets, capsules, emulsions
- Warehouse with 1680 pallet spaces
Budapest
HUMarketing and sales
Products
Inside the production
Industries
Processes & technical limits
| Processes | Tolerance | Max. part | Weight | Lot size | Materials |
|---|---|---|---|---|---|
| Manufacture of medicines (manufacturing operation)Plastics | – | – | – | – | Protein hydrolysate (thymus peptides), Benzyl benzoate, Hydrocortisone, Calcium, Vitamin D3 (colecalciferol), Plant extracts |
| Packaging of solid dosage formsAssembly | – | – | – | – | Tablets, Capsules |
| Quality control and releases (LFGB, GMP, AMG)Testing | – | – | – | – | – |
1 Anlagen & Maschinen
| Machine | Manufacturer / model | Quantity | Working area | Year built | Site |
|---|---|---|---|---|---|
| Warehouse | – | – | 1680 pallet spaces | – | Seevetal |
Additional services
Quality and certifications
Quality assurance takes place at the GDP-certified Hamburg site; at the GMP-certified Seevetal site, quality control and releases according to LFGB, GMP and AMG are carried out. In 2008, the first joint pharmacovigilance inspection by BfArM, PEI and the Hamburg state authority took place.
| Evidence | Hamburg | Seevetal |
|---|---|---|
| GMP | ||
| GDP | ||
| Releases according to LFGB, GMP, AMG |
History
- 1888
Foundation of the pharmaceutical manufacturer Pharma Stroschein, later acquired
- 1974
Acquisition of Pharma Stroschein by Dr. Detlef Strathmann; cornerstone of Strathmann GmbH & Co. KG
- 1978
Foundation of the manufacturing operation Biokirch GmbH in Seevetal
- 1989
Distribution of the vaccines Gynatren and SolcoUrovac/StroVac for immunotherapy
- 1994
Distribution and manufacture of Thym-Uvocal, the first thymus peptide extract for immunotherapy in Germany
- 1996
Introduction of the hydrocortisone cream Ebenol
- 1997
Start of biotechnological developments and contract manufacturing for biotech companies
- 1999
Exclusive partner of a British company for Adcal-D3
- 2004
Marketing authorization for Antiscabiosum
- 2007
Sale of Strathmann Biotec GmbH & Co. KG to Richter-Helm Biologics
- 2008
First joint pharmacovigilance inspection by BfArM, PEI and the Hamburg state authority
- 2011–2013
Marketing authorizations for SolcoUrovac (StroVac) in several Asian and Eurasian countries
- 2015
Marketing authorization for Myopridin injection solution
- 2017
Marketing authorization for Myopridin 3 mg tablets
- 2018
Strathmann becomes part of the Dermapharm group
- 2020
Relaunch of Pollstimol (BPH, abacterial prostatitis)
- 2021
Merger of Biokirch GmbH with Strathmann GmbH & Co. KG
- 2022
Relocation of the entire Seevetal operation (production, laboratory, warehouse) into modernized premises